Solstice Oncology, Inc. — Form D

Solstice Oncology, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-09. The offering totals $298.4M, of which $121.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-03-09
• Form: D
• Accession: 0002116600-26-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $298.4M
• Amount sold: $121.3M
• Remaining: $177.1M
• Investors: 8
• Date of first sale: 2026-02-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-575833

Issuer

• Name: Solstice Oncology, Inc.
• CIK: 0002116600
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2026
• Address: 200 BERKELEY ST., 18TH FLOOR, BOSTON, MA, 02116
• Phone: 617-982-2331

Officers, directors & promoters (9)

More

• CIK 2116600 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search